111 related articles for article (PubMed ID: 9391718)
1. Increased soluble P-selectin following myocardial infarction: a new marker for the progression of atherosclerosis.
Blann AD; Faragher EB; McCollum CN
Blood Coagul Fibrinolysis; 1997 Oct; 8(7):383-90. PubMed ID: 9391718
[TBL] [Abstract][Full Text] [Related]
2. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
[TBL] [Abstract][Full Text] [Related]
3. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
[TBL] [Abstract][Full Text] [Related]
4. Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients.
Di Nisio M; Di Febbo C; Moretta V; Guglielmi MD; Stuppia L; Cuccurullo F; Porreca E
Thromb Haemost; 2007 Sep; 98(3):642-6. PubMed ID: 17849054
[TBL] [Abstract][Full Text] [Related]
5. [Decreased plasma soluble P-selectin level in coronary sinus after successful coronary angioplasty in patients with unstable angina].
Doi N; Nishio K; Nakatani H; Hayashi T; Miyamoto S; Hashimoto T; Dohi K
J Cardiol; 1999 May; 33(5):251-6. PubMed ID: 10354952
[TBL] [Abstract][Full Text] [Related]
6. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Blann AD; Lip GY; Beevers DG; McCollum CN
Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
[TBL] [Abstract][Full Text] [Related]
7. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
Blann AD; Dobrotova M; Kubisz P; McCollum CN
Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
[TBL] [Abstract][Full Text] [Related]
8. Relationship of homocysteine to markers of platelet and endothelial activation in "high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Martin SC; Felmeden DC; Blann AD; Beevers GD; Lip GY
Int J Cardiol; 2004 Apr; 94(2-3):293-300. PubMed ID: 15093996
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
10. Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis.
Güray U; Erbay AR; Güray Y; Yilmaz MB; Boyaci AA; Sasmaz H; Korkmaz S; Kütük E
Int J Cardiol; 2004 Aug; 96(2):235-40. PubMed ID: 15262039
[TBL] [Abstract][Full Text] [Related]
11. Soluble P selectin in peripheral vascular disease: relationship to the location and extent of atherosclerotic disease and its risk factors.
Blann AD; Seigneur M; Boisseau MR; Taberner DA; McCollum CN
Blood Coagul Fibrinolysis; 1996 Nov; 7(8):789-93. PubMed ID: 9034560
[TBL] [Abstract][Full Text] [Related]
12. [Selectins in the pathogenesis and diagnosis of early atherosclerotic changes in children and adolescents with risk factors (obesity, hypertension and diabetes)].
Głowińska B; Urban M; Peczyńska J; Florys B
Przegl Lek; 2004; 61(9):935-9. PubMed ID: 15803902
[TBL] [Abstract][Full Text] [Related]
13. Increased soluble P-selectin in peripheral artery disease: a new marker for the progression of atherosclerosis.
Blann AD; McCollum CN
Thromb Haemost; 1998 Dec; 80(6):1031-2. PubMed ID: 9869182
[No Abstract] [Full Text] [Related]
14. [Changes of plasma von Willebrond factor and soluble E-selectin levels in patients with coronary artery disease].
Lin GQ; Jiang HH; Li YQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):399-402. PubMed ID: 16190382
[TBL] [Abstract][Full Text] [Related]
15. Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation: relationship to plasma von Willebrand factor and soluble E-selectin levels.
Freestone B; Chong AY; Nuttall S; Lip GY
Thromb Res; 2008; 122(1):85-90. PubMed ID: 17996280
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a 'real-world' community cohort of patients with atrial fibrillation.
Krishnamoorthy S; Khoo CW; Lim HS; Lane DA; Pignatelli P; Basili S; Violi F; Lip GY
Eur J Clin Invest; 2013 Oct; 43(10):1032-8. PubMed ID: 23961715
[TBL] [Abstract][Full Text] [Related]
17. The expression of von Willebrand factor, soluble thrombomodulin, and soluble p-selectin during orthotopic liver transplantation.
Wang YI; Li G; Zhang Y; Gao W; Yao Z
Transplant Proc; 2007; 39(1):172-5. PubMed ID: 17275499
[TBL] [Abstract][Full Text] [Related]
18. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor.
Makin AJ; Blann AD; Chung NA; Silverman SH; Lip GY
Eur Heart J; 2004 Mar; 25(5):371-6. PubMed ID: 15033248
[TBL] [Abstract][Full Text] [Related]
19. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
[TBL] [Abstract][Full Text] [Related]
20. Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease.
Freestone B; Lip GY; Chong AY; Nadar S; Lee KW; Blann AD
Thromb Haemost; 2005 Oct; 94(4):702-6. PubMed ID: 16270620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
